Oceanside, California USA, Apr 3 – AOTI Inc. announced today that over 1,000,000 home treatments have been provided with its revolutionary patented Topical Wound Oxygen (TWO2) therapy. “This is a momentous milestone for our company and a testament to the clinical...
Oceanside, California USA, Feb 17 – AOTI Inc. announced today that it’s fully owned USA operating subsidiary, Advanced Oxygen Therapy Inc., has been awarded DMEPOS accreditation for Home/Durable Medical Equipment Services by the Accreditation Commission for Health...
Oceanside, California USA, Feb 14 – AOTI Inc. announced today that it will again be providing an expansive Clinical Education program at the Desert Foot conference, East and Midwest Podiatric Residency summits, which are the leading conferences focused on the Veterans...
Oceanside, California USA, Aug 16 – AOTI Inc. announced today the U.S. Patent and Trademark Office have granted its Patent Application No. 14/150,178 – CONTROLLER FOR AN EXTREMITY HYPERBARIC DEVICE that will now issue as U.S. Patent No. 9,421,147. This is the...
Oceanside, California USA, Apr 16 – AOTI Inc. announced today the 10,000th patient has been treated with its revolutionary patented Topical Wound Oxygen Therapy. “This is a momentous milestone for our company and a testament to the clinical efficacy of TWO2 therapy,...
